Sarepta Therapeutics Inc.'s bid for the full Federal Circuit’s review of a revived gene-therapy patent dispute with RegenxBio ...

The Looker selects products independently. If you purchase something from our posts, we may earn a small commission. From ...

Harnessing technology transferred from VTT Technical Research Centre of Finland, Proteins.1 is developing a PCR-like ...

Khondrion today announced that the first patient has been dosed in the pivotal, randomized, placebo-controlled Phase 3 KHENERFIN study (NCT 06451757) evaluating the efficacy and safety of ...

Nanomedicine prompts RNA to make protein-based drugs to treat diseases. Now we can fine-tune protein production by dialling ...

Scientists now recognize that spontaneous DNA errors, which we acquire in early development all the way until our last breath ...

A team of University of Alberta researchers has developed a cardio-oncology drug that protects the heart from chemotherapy ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

First-in-class, covalent, oral small molecule inhibitor targeting IRF5IRF5 is a genetically validated driver of autoimmune diseases, including ...

Quarterly RNA drug plozasiran turns off a liver gene, sharply lowering life‑threatening pancreatitis attacks in a rare ...

The domestication of dogs began approximately 30,000-50,000 years ago with Eurasian gray wolves, marking the first time any ...

This review examines how next-generation protein sequencing and analysis technologies are expanding proteomics beyond the ...